about
Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer.Genomic and molecular characterization of esophageal squamous cell carcinomaZNF750 is a lineage-specific tumour suppressor in squamous cell carcinoma.KPT-330 has antitumour activity against non-small cell lung cancer.Improved expression and purification of recombinant human serum albumin from transgenic tobacco suspension culture.LNK (SH2B3): paradoxical effects in ovarian cancer.Genome sequence and characterization of a new virus infecting Mikania micrantha H.B.K.SETDB1 accelerates tumourigenesis by regulating the WNT signalling pathway.Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma.Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse.The characterization of SaPIN2b, a plant trichome-localized proteinase inhibitor from Solanum americanum.Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancersComprehensive mutational analysis of primary and relapse acute promyelocytic leukemia.PIAS4 is an activator of hypoxia signalling via VHL suppression during growth of pancreatic cancer cells.Laminin-5γ-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration, and invasion by modulating signaling of EGFR.Mutational profiling of a MonoMAC syndrome family with GATA2 deficiency.Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD).Identification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomas.The genomic landscape of nasopharyngeal carcinoma.BCL6 promotes glioma and serves as a therapeutic target.Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin.Mutational profiling of acute lymphoblastic leukemia with testicular relapse.Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma.Super-enhancers promote transcriptional dysregulation in nasopharyngeal carcinoma.Culture of Escherichia coli in SOC medium improves the cloning efficiency of toxic protein genes.Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma.Targeting the vulnerability to NAD+ depletion in B-cell acute lymphoblastic leukemia.Using silica particles to isolate total RNA from plant tissues recalcitrant to extraction in guanidine thiocyanate.Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia.Diagnosis and relapse: cytogenetically normal acute myelogenous leukemia without FLT3-ITD or MLL-PTD.Increased Expression of the Long Non-coding RNA LINC01503, Regulated by TP63, in Squamous Cell Carcinoma and Effects on Oncogenic Activities of Cancer Cell Lines.Purification and characterization of native and recombinant SaPIN2a, a plant sieve element-localized proteinase inhibitor.Clonality and clonal evolution analysis of paediatric ALL based on B-cell receptor/T-cell receptor rearrangement.Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glioblastoma.Profiling the B/T cell receptor repertoire of lymphocyte derived cell linesCo-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progressionASXL2 regulates hematopoiesis in mice and its deficiency promotes myeloid expansionFunctional Genome-wide Screening Identifies Targets and Pathways Sensitizing Pancreatic Cancer Cells to DasatinibLNK suppresses interferon signaling in melanomaBromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma
P50
Q27308683-831CEA2B-5DBF-4336-B2AB-888473BB8A36Q28657686-D64CB7E6-0475-44A6-84F6-3024C55EB922Q33634311-794C2FE7-E3E3-4ABE-9232-E1211248478CQ33918079-7E88659E-F0F7-4D61-B0D2-8EC4849639B2Q33962703-90CB1222-1C66-40D8-8444-E929C32C1A67Q34302585-BC351EE4-CC59-45D3-9464-83158C022BD4Q34804225-D92FF601-8C4E-4DC5-A03D-6964CF67C570Q35097426-E019DD20-DFFD-4AB2-80B6-16B3F523BCC0Q35562809-BECD4205-DBDB-439F-BD37-58A703C0F03BQ36322776-763393E5-F028-44AD-AA73-118197C5D69BQ36432611-A19E3CD2-5EC9-48E3-9A6B-2E3A9AB38930Q36762760-FCE73569-6687-4262-92B5-ADD47FADDC2EQ37150061-46BB6458-ADCE-4C0C-A21D-87F452350619Q37214337-F6B30CE1-1418-4FB7-BFA4-F138BEEDAF76Q37428997-1208E14D-8439-4308-BF21-C2FC1465ABD0Q37559777-211AAFA3-933F-4203-A320-293BB3839E39Q37559783-03E330A2-BE70-4862-B114-F9BF6A5C5142Q38599134-80B4C03A-70D9-40E3-9721-C6DC79040B7AQ38982367-F36336D3-E924-4C15-A905-40E227B397D9Q40267907-B09487C2-4BB8-4928-A169-29D4FF2C4EA4Q41550563-EA9EC09B-F777-4549-B1F3-D952C9673D78Q42318643-B39EA09F-CA9D-4B77-A771-D737EFBBFE67Q42773650-29E57777-6C7D-4AC0-83F9-BA9B9BA61C19Q42777868-7F95B0E9-40AE-4548-8901-4B790ACD1FD6Q45923869-3B4F550C-E0E3-4F57-8A5D-A27D618297B8Q46204388-F10D3DA5-B890-4C8D-9E50-EE818D093FECQ46774124-6436AF54-C011-41F2-A21E-449F699322B2Q46827783-3FF5DD75-03AD-4CC2-BE67-637A4B3CF64EQ47370037-7C7E473C-BB1E-4A23-AEEF-42C22100CC87Q48034587-60707F3D-9EF8-4ED0-9BB7-6C7C103BDE34Q49896621-FB4021AE-12C0-4968-829A-F6D994C168B7Q50911150-2FD1F576-9521-43B2-BAB0-60F6A27D0D11Q52726913-165444F5-9996-4357-A305-F2FADFCB9181Q55457087-E9011F64-070E-4E65-80D6-7C30A551A9B8Q57052690-A76B9C94-F96F-4604-87FC-E7D0FF5F8CEEQ58761894-D8C7A5C9-EB44-405B-91B0-975183526C3DQ59797105-B7714206-ECDD-40B5-8AFF-EB4B2A9262A9Q60304301-020607A1-CC5B-4F56-9A8E-9902967E351CQ64052024-AA93C864-7540-4639-A1DC-B0DD761F580DQ64063137-1CB6765F-5184-46EE-9649-DD6E5A32C2E9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ling-Wen Ding
@ast
Ling-Wen Ding
@en
Ling-Wen Ding
@es
Ling-Wen Ding
@nl
Ling-Wen Ding
@sl
type
label
Ling-Wen Ding
@ast
Ling-Wen Ding
@en
Ling-Wen Ding
@es
Ling-Wen Ding
@nl
Ling-Wen Ding
@sl
prefLabel
Ling-Wen Ding
@ast
Ling-Wen Ding
@en
Ling-Wen Ding
@es
Ling-Wen Ding
@nl
Ling-Wen Ding
@sl
P106
P1153
27168853700
P31
P496
0000-0003-0022-1551